<div id="readability-page-1"><p>Representative Val T. Hoyle (D-Oregon) recently sold shares of McKesson Corporation <span>NYSE: MCK<span></span></span>. In a filing disclosed on October 10th, the Representative disclosed that they had sold between $1,001 and $15,000 in McKesson stock on September 23rd. The trade occurred in the Representative's &#34;FIDELITY ROLLOVER IRA&#34; account.</p><ul><li>More Than Yield: 5 Stocks Beating the Market and Hiking Dividends</li></ul><p>Representative Val T. Hoyle also recently made the following trade(s): </p><ul><li>Sold $1,001 - $15,000 in shares of Marriott International <span>NASDAQ: MAR<span></span></span> on 9/23/2025. </li><li>Sold $1,001 - $15,000 in shares of Transdigm Group <span>NYSE: TDG<span></span></span> on 9/23/2025. </li><li>Sold $1,001 - $15,000 in shares of H&amp;R Block <span>NYSE: HRB<span></span></span> on 9/23/2025. </li><li>Sold $1,001 - $15,000 in shares of NIKE <span>NYSE: NKE<span></span></span> on 9/23/2025. </li><li>Sold $1,001 - $15,000 in shares of Bank of New York Mellon <span>NYSE: BK<span></span></span> on 9/23/2025. </li><li>Sold $1,001 - $15,000 in shares of Cisco Systems <span>NASDAQ: CSCO<span></span></span> on 9/23/2025. </li><li>Sold $1,001 - $15,000 in shares of Capital One Financial <span>NYSE: COF<span></span></span> on 9/23/2025. </li><li>Sold $1,001 - $15,000 in shares of Pentair <span>NYSE: PNR<span></span></span> on 9/23/2025. </li><li>Sold $1,001 - $15,000 in shares of Heico <span>NYSE: HEI.A<span></span></span> on 9/23/2025. </li><li>Sold $1,001 - $15,000 in shares of Target <span>NYSE: TGT<span></span></span> on 9/23/2025. </li></ul><h2>McKesson Stock Performance</h2><p>MCK opened at $763.89 on Friday. The business's 50-day simple moving average is $707.48 and its 200-day simple moving average is $706.09. McKesson Corporation has a one year low of $492.39 and a one year high of $776.14. The stock has a market capitalization of $95.01 billion, a P/E ratio of 30.46, a price-to-earnings-growth ratio of 1.37 and a beta of 0.52. </p><ul><li>3 Safe Dividend Stocks as Investors Seek to Reset Diversification</li></ul><p>McKesson (NYSE:MCK - Get Free Report) last issued its quarterly earnings results on Wednesday, August 6th. The company reported $8.26 earnings per share (EPS) for the quarter, missing the consensus estimate of $8.33 by ($0.07). The company had revenue of $97.83 billion during the quarter, compared to analyst estimates of $95.93 billion. McKesson had a net margin of 0.84% and a negative return on equity of 196.66%. The business's revenue was up 23.4% on a year-over-year basis. During the same quarter last year, the firm earned $7.88 EPS.  On average, equities research analysts forecast that  McKesson Corporation will post 32.77 EPS for the current fiscal year. </p><h2>McKesson Increases Dividend</h2><p>The firm also recently declared a quarterly dividend, which was paid on Wednesday, October 1st. Shareholders of record on Tuesday, September 2nd were issued a dividend of $0.82 per share. This is a positive change from McKesson's previous quarterly dividend of $0.71. The ex-dividend date of this dividend was Tuesday, September 2nd. This represents a $3.28 dividend on an annualized basis and a yield of 0.4%. McKesson's dividend payout ratio (DPR) is presently 13.08%. </p><h2>Analysts Set New Price Targets</h2><ul><li> 3 Stocks to Consider With a Possible Recession on the Table</li></ul><p>A number of research firms have recently commented on MCK. Mizuho upped their price objective on McKesson from $750.00 to $770.00 and gave the stock a &#34;neutral&#34; rating in a report on Wednesday, September 24th. Cowen  restated a &#34;buy&#34; rating on shares of McKesson in a research note on Wednesday, September 24th. JPMorgan Chase &amp; Co. raised their price objective on shares of McKesson from $821.00 to $853.00 and gave the company an &#34;overweight&#34; rating in a research note on Friday, September 26th. Evercore ISI raised their target price on shares of McKesson from $800.00 to $825.00 and gave the stock an &#34;outperform&#34; rating in a report on Wednesday, September 24th. Finally, Deutsche Bank Aktiengesellschaft raised their price objective on shares of McKesson from $775.00 to $856.00 and gave the stock a &#34;buy&#34; rating in a research note on Wednesday, September 24th. One equities research analyst  has rated the stock with a Strong Buy rating, twelve have assigned  a Buy rating and three have given a Hold rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of &#34;Moderate Buy&#34; and a consensus price target of $829.08.</p><p><b>Check Out Our Latest Analysis on MCK</b></p><h2>Hedge Funds Weigh In On McKesson</h2><p>A number of large investors have recently modified their holdings of the stock. Solstein Capital LLC increased its stake in  McKesson by 171.4% in the second quarter. Solstein Capital LLC now owns 38 shares of the company's stock valued at $28,000 after purchasing an additional 24 shares in the last quarter.  State of Wyoming acquired a new stake in shares of  McKesson during the 2nd quarter worth about $29,000.  GFG Capital LLC bought a new position in  McKesson in the 2nd quarter valued at about $30,000.  CBIZ Investment Advisory Services LLC raised its holdings in  McKesson by 1,366.7% in the 1st quarter. CBIZ Investment Advisory Services LLC now owns 44 shares of the company's stock valued at $30,000 after acquiring an additional 41 shares during the period.  Finally, Bank of Jackson Hole Trust grew its position in shares of  McKesson by 64.3% during the 1st quarter. Bank of Jackson Hole Trust now owns 46 shares of the company's stock worth $29,000 after purchasing an additional 18 shares in the last quarter. 85.07% of the stock is currently owned by institutional investors and hedge funds. </p><h2>Insider Activity at McKesson</h2><p>In related news, CAO Napoleon B. Rutledge, Jr. sold 329 shares of the stock in a transaction that occurred on Friday, August 8th. The shares were sold at an average price of $663.67, for a total transaction of $218,347.43. Following the sale, the chief accounting officer owned 657 shares in the company, valued at approximately $436,031.19. This trade represents a 33.37% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Brian S. Tyler sold 11,930 shares of the firm's stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $705.63, for a total transaction of $8,418,165.90. Following the transaction, the chief executive officer directly owned 4,012 shares of the company's stock, valued at $2,830,987.56. The trade was a 74.83% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 24,189 shares of company stock worth $16,722,190 in the last quarter. 0.08% of the stock is currently owned by company insiders. </p><h2>About Representative Hoyle</h2><p>Val Hoyle (Democratic Party) is a member of the U.S. House, representing Oregon's 4th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027.  Hoyle (Democratic Party) is running for re-election to the U.S. House to represent Oregon's 4th Congressional District. She declared candidacy for the 2026 election.  Val Hoyle was born in California and lives in Springfield, Oregon. Hoyle graduated from Merrimack High School. She earned a B.A. in political science from Emmanuel College in 1992. Her career experience includes working as a director at United Way of Lane County, a policy fellow at Wayne Morse Center for Law and Politics, and a commissioner at the Oregon Bureau of Labor and Industries. Hoyle has also worked in domestic and international sales, as well as manufacturing distribution.</p><h2>McKesson Company Profile</h2> (Get Free Report)<p>McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.</p><h2>Read More</h2><ul><li>Five stocks we like better than McKesson</li><li>How the NYSE and NASDAQ are Different, Why That Matters to Investors</li><li>MarketBeat Week in Review – 10/06 - 10/10</li><li>Which Wall Street Analysts are the Most Accurate?</li><li>3 Heavily Shorted Stocks That Could Pop on Rate Cuts</li><li>How Can Investors Benefit From After-Hours Trading</li><li>Broadcom Gets Second $420 Target as CPO Win Boosts Outlook</li></ul><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in McKesson Right Now?</h2><p>Before you consider McKesson, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and McKesson wasn't on the list.</p><p>While McKesson currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Representative Val T. Hoyle (D-Oregon) sold shares of McKesson Corporation (NYSE:MCK) valued between $1,001 and $15,000 on September 23rd, as disclosed in a filing on October 10th. The transaction occurred in her "FIDELITY ROLLOVER IRA" account. Hoyle also sold shares of several other companies on the same date. McKesson's stock opened at $763.89, with a market cap of $95.01 billion and a recent quarterly dividend increase to $0.82 per share.</p>

Rep. Val T. Hoyle Sells Off Shares of McKesson Corporation (NYSE:MCK)